The expression of the retinoblastoma susceptibility (RB) gene was inve
stigated in P19 embryonal carcinoma cells and in these cells induced t
o differentiate with retinoic acid (RA) or with dimethyl sulfoxide (DM
SO). In undifferentiated cells very low levels of RB mRNA and protein
were present. DMSO-treated P19 cell cultures develop into mesodermal a
nd endodermal cells and RB expression increased only slightly in these
differentiating celts. RA-treated P19 cells develop into neuroectoder
m and this differentiation was accompanied by a marked increase in RB
expression with mRNA levels increasing 15 fold by 4-6 days following i
nitiation of RA treatment. No such increase occurred in mutant cells t
hat fail to respond to RA. The RB promoter did not appear to be direct
ly activated by RA. Nevertheless, the increase in RB expression in RA-
treated cells appeared to be due to enhanced initiation of transcripti
on because cells transfected with a reporter gene driven by the RB pro
moter expressed the reporter gene with kinetics similar to that of the
RB gene. Thus the activation of the RB gene appears to be achieved in
directly by RA-induced factor(s) in differentiating neuroectodermal ce
lls. The post-mitotic neurons that developed in RA-treated cultured co
ntained only the hypophosphorylated form of the RB protein. Recent stu
dies (Clarke et aL, 1992; Jacks et al., 1992; Lee et al., 1992) have s
hown that mice lacking the RB gene have abnormalities in early brain d
evelopment suggesting that the rapid rise in RB expression and the hyp
ophosphorylation of the protein are essential for neuronal cell differ
entiation.